Your cart:$0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Aripiprazole - Abilify

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Abilify

Generic Abilify

Aripiprazole 20mg

Generic Abilify is used for treating agitation caused by schizophrenia or bipolar disorder.

More info »
$2.39 Buy now!
Choose Your language:
Social bookmarks:
Testimonials
Thank you for your mail. Yes, I received my order and everithing is fine with it. Thank you very much for the four extra pills you had, I really do appreciate it. I should recommand your site to friends and I'll come back to you soon.
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM ... - MarketWatch (press release)
SunHerald
Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM ... - EON: Enhanced Online News (press release)
Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM
Long-term Injectable Drug Effective for Schizophrenia - Medscape
Long-term Injectable Drug Effective for SchizophreniaMedscapeMay 11, 2012 (Philadelphia, Pennsylvania) — Intramuscular depot aripiprazole is a safe and tolerable option for long-term maintenance treatment of schizophrenia, according to several presentations from a new large trial presented here at the American
Abilify Does Well in Depot Version - MedPage Today
Abilify Does Well in Depot VersionMedPage TodayNote that a phase III study was halted at a preplanned interim data point which demonstrated fewer relapses with depot aripiprazole compared with placebo for long-term maintenance in schizophrenia
Treatment of refractory catatonic schizophrenia with low dose aripiprazole - 7thSpace Interactive (press release)
Treatment of refractory catatonic schizophrenia with low dose aripiprazole7thSpace Interactive (press release)However, treatment with low-dose aripiprazole dramatically improved the patient's psychotic symptoms and extrapyramidal symptoms
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News